Pune, India, Nov. 15, 2021 (GLOBE NEWSWIRE) -- The global home infusion therapy market size is likely to USD 86.89 billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route.
According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% between 2020 and 2027.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/home-infusion-therapy-market-102989
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR | 2.2% |
| 2027 Value Projection | USD 86.89 billion |
| Base Year | 2019 |
| Market Size in 2019 | USD 27.25 billion |
| Historical Data for | 2016 to 2018 |
| No. of Pages | 128 |
| Segments covered | By Product, Immunoglobulin Therapy, By Indication, Anti-Infective, |
| Growth Drivers | Drugs Segment to Hold Dominance Owing to Increasing Incidences of Cancer |
| North America to Dominate Market on Account of Rising Adoption of Innovative Technologies | |
| Handful of Vendors Covering Majority Shares Attributed to Massive Investment on Innovative Devices |
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989
The Report Answers the Following Queries
- What is the nature of the market and how fierce is its competition?
- What are the key industry insights to the market?
- What strategies are adopted by players to gain momentum in the market?
- How is the COVID19 pandemic helping the market to grow?
Drivers & Restraints-
Lockdowns Amid COVID-19 Pandemic to Bode Well for the Market
The increasing prevalence of the geriatric population and their vulnerability towards chronic diseases such as cancer, diabetes, and cardiac issues among others stands as major home infusion therapy market devices. In addition to this, the increasing cases of hospital-acquired infections are also propelling people to opt for medical services at home. This, coupled with cost-efficient home treatment faster recovery at home than hospital are likely to bode well for the market.
On the flip side, most of the developing nations lack reimbursement structure and policy for home treatment which ultimately increases the out-of-pocket expenditure. This, coupled with a lack of proper medical assistance and limited sources in a home setting, may cause hindrance to the market. Nevertheless, the increasing number of innovations in the medical sector and the advent of devices such as portable infusion pumps, and others are likely to create lucrative growth opportunities for the market. Furthermore, the current pandemic of coronavirus that propelled people to stay at home is projected to promote the home infusion therapy market growth.
Segment-
Drugs Segment to Hold Dominance Owing to Increasing Incidences of Cancer
Based on segmentation by product, the drugs segment earned the highest home infusion therapy market share on account of the increasing number of immune diseases worldwide and the rising prevalence of cancer. Besides this, the devices segment earned a 6.6% share and is likely to witness significant growth in the coming years on account of increasing technological advancements in the delivery of home medication system for various purposes.
Quick Buy - Home Infusion Therapy Market: https://www.fortunebusinessinsights.com/checkout-page/102989
Regional Analysis-
North America to Dominate Market on Account of Rising Adoption of Innovative Technologies
Regionally, North America emerged at the top with a revenue of USD 10.53 billion in 2019. The growth of this region is attributable to the development of delivery devices for home medication and its increasing adoption. Besides this, the rising number of patients and rapid adoption of the latest technologies are factors responsible for the dominance of this region.
Besides this, the Asia Pacific market is anticipated to witness rapid growth in the forecast duration on account of the increasing prevalence of diabetes, heart issues, cancer, and other long-lasting diseases in the region.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/home-infusion-therapy-market-102989
Competitive Landscape-
Handful of Vendors Covering Majority Shares Attributed to Massive Investment on Innovative Devices
The global home infusion therapy market is dominated by a handful of companies thereby depicting a consolidated nature of the market. These include Option Care Health Inc., Optum Inc., Melsungen AG, and Braun. The dominance of these players is accountable for the expansion of geographical footprint, major investments in the development of innovative devices, and infusion pumps.
Notable Industry Developments of the Home Infusion Therapy Market include:
July 2019 – Food and Drug Administration approved the first and ready-to-use insulin called Myxredlin manufactured by Baxter.
December 2019 – Diplomat and Optum Inc. entered into a partnership for specialty infusion and pharmaceutical services in the U.S. The key objective behind this merger strategy is to serve patients with chronic diseases with therapeutic measures such as oncology and immunology in the entire U.S.
Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:
- Optum, Inc.
- Infusystem
- Option Care Health Inc.
- Moog Inc.
- CareCentrix, Inc.
- B. Braun Melsungen AG
- Lincare Holdings Inc.
- Baxter
- Promptcare
- BriovaRx Infusion Services
- Other players
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/home-infusion-therapy-market-102989
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Key Chronic Diseases, 2019, Key Countries/Regions
- New Product Launches for Home Infusion Therapy
- Covid-19 Impact on the Home Infusion Therapy, and Key Steps Taken by Market Players
- Key Industry Development such as Mergers, Acquisition, and Partnerships
- Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Devices
- Drugs
- Services
- Market Analysis, Insights and Forecast – By Indication
- Anti-Infective
- Chemotherapy
- Hydration Therapy
- Enternal Nutrition
- Total Parenteral Nutrition
- Immunoglobulin Therapy
- Others
- Market Analysis, Insights and Forecast – By Country/Sub-region
- North America
- Europe
- Asia Pacific
- Rest of the World
- North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Devices
- Drugs
- Services
- Market Analysis, Insights and Forecast – By Indication
- Anti-Infective
- Chemotherapy
- Hydration Therapy
- Enternal Nutrition
- Total Parenteral Nutrition
- Immunoglobulin Therapy
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
Continued...
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
